Provepharm Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Private

  • Employees
  • 150

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 9

  • Investments
  • 3

Provepharm General Information

Description

Manufacturer of medical dyes and pharmaceutical solutions designed to enhance surgical precision and clinical visualization. The company's technology utilizes organic chemistry and advanced formulation technologies to provide patented medical dyes and specialty drugs, enabling healthcare professionals to improve surgical detection and patient outcomes.

Contact Information

Website
www.provepharm.com
Formerly Known As
Provence Technologies
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 22, rue Marc Donadille
  • 13013 Marseille
  • France
+33 04
Primary Industry
Pharmaceuticals
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • 22, rue Marc Donadille
  • 13013 Marseille
  • France
+33 04

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Provepharm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Provepharm‘s full profile, request access.

Request a free trial

Provepharm Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of medical dyes and pharmaceutical solutions designed to enhance surgical precision and clinical visualizat
Pharmaceuticals
Marseille, France
150 As of 2025

North Augusta, SC
 

Hyderabad, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Provepharm Competitors (23)

One of Provepharm’s 23 competitors is AmbioPharm, a Private Equity-Backed company based in North Augusta, SC.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AmbioPharm Private Equity-Backed North Augusta, SC
Dr. Reddy's Corporation Hyderabad, India
Capsugel Private Equity-Backed Morristown, NJ
Biotest Formerly PE-Backed Dreieich, Germany
CordenPharma Private Equity-Backed Basel, Switzerland
You’re viewing 5 of 23 competitors. Get the full list »

Provepharm Patents

  • 112

    Total Documents Applications and Grants

  • Total Patents Families

  • 70

    Granted

  • 18

    Pending

  • Expiring in next 12 mo

Provepharm Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4837562-A1 Iodine-free indocyanine green j-aggregates Pending 07-May-2025
EP-4519360-A1 Crystalline indocyanine green and method for the production thereof Pending 06-May-2022
EP-4523709-A2 Crystalline indocyanine green and method for the production thereof Pending 06-May-2022
EP-4523709-A3 Crystalline indocyanine green and method for the production thereof Pending 06-May-2022
US-20250340739-A1 Crystalline indocyanine green and method for the production thereof Pending 06-May-2022 C09B23/086
To view Provepharm’s complete patent history, request access »

Provepharm Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Provepharm Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Provepharm‘s full profile, request access.

Request a free trial

Provepharm Investments & Acquisitions (3)

Provepharm’s most recent deal was a Buyout/LBO with Apollo Pharmaceuticals. The deal was made on 02-Dec-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Apollo Pharmaceuticals 02-Dec-2020 Buyout/LBO Pharmaceuticals
PYTHEAS Technology 25-Jul-2017 Seed Round Electrical Equipment
Synprosis 02-Jun-2014 Merger/Acquisition Drug Discovery
To view Provepharm’s complete investments and acquisitions history, request access »

Provepharm Exits (1)

Provepharm’s most recent exit was on 02-Jun-2014 from Synprosis. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Synprosis 02-Jun-2014 Completed
To view Provepharm’s complete exits history, request access »

Provepharm FAQs

  • When was Provepharm founded?

    Provepharm was founded in 1998.

  • Where is Provepharm headquartered?

    Provepharm is headquartered in Marseille, France.

  • What is the size of Provepharm?

    Provepharm has 150 total employees.

  • What industry is Provepharm in?

    Provepharm’s primary industry is Pharmaceuticals.

  • Is Provepharm a private or public company?

    Provepharm is a Private company.

  • What is Provepharm’s current revenue?

    The current revenue for Provepharm is .

  • How much funding has Provepharm raised over time?

    Provepharm has raised $195M.

  • Who are Provepharm’s investors?

    Cathay Capital, ARCHIMED, Région Sud Investissement, Smalt Capital, and Sofipaca Capital Investissement have invested in Provepharm.

  • Who are Provepharm’s competitors?

    AmbioPharm, Dr. Reddy's, Capsugel, Biotest, and CordenPharma are some of the 23 competitors of Provepharm.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process